MAPK1 and leukemia: To evaluate the status of the MAPK/ERK and PI3K/AKT pathways in leukemia cells treated with AZD0364 and ZSTK474, we analyzed the activation of ERK1/2 and AKT using Muse PI3K/MAPK dual detection kit.